Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease

• Κύριοι συγγραφείς: V. I. Ignatyeva (Συγγραφέας), S. V. Moiseev (Συγγραφέας), N. M. Bulanov (Συγγραφέας), E. A. Karovajkina (Συγγραφέας), A S. Moiseev (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: IRBIS LLC, 2019-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Fabry disease (FD) is a severe lysosome storage disease caused by congenital deficiency of the enzyme α-galactosidase A and characterized by the risk of renal failure combined with cardiovascular and CNS complications. According to the currently available information, the early start of enzyme repla...